Details checkedClinical trial listing onlyCheckedregistry

Nova Scotia anatomy-based MED-EL electrode array selection study

Also known as: Anatomy-Based Electrode Array Selection, OTOPLAN, FLEX26, FLEX28, FLEXSOFT, NSHSCMEDEL, NCT06189274

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Device

Modality

Cochlear/Auditory Implant

Stage

Interventional/NA

Status

Unknown

Target Gene

—

Route / Mode

Implantable cochlear implant electrode selection workflow

Confidence

80%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-09

Geography

Canada

Population

adult, single-sided-deafness, cochlear-implant, imaging-guided-selection

Trial IDs

Mechanism

Patient-specific cochlear implant electrode array selection using pre-operative imaging, compared with standard FLEX28 array selection, in adults with single-sided deafness.

Indications

Hearing Loss Single-Sided Deafness Sensorineural Hearing Loss

Notes

ClinicalTrials.gov lists Nova Scotia Health Authority as lead sponsor and MED-EL Corporation as collaborator. The generated company label MED-EL was too strong; this is an institution-led study using MED-EL cochlear implant arrays and OTOPLAN.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, allCompanies, isIndustrySponsored, programType, modality, stage, status...

IDs: NCT06189274, NSHSCMEDEL, OTOPLAN

Open

Key Events

2024-01-03

Anatomy-based electrode selection study first posted

Clinical Trials (1)

NCT06189274

Data Checks